Form4insider filings, from the source

SEC Form 4/A · accession 0001140361-18-019870

BIOMARIN PHARMACEUTICAL INC · BMRN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jeffrey Robert Ajer
Officer — EVP, Chief Commercial Officer
Period of report
Feb 26, 2018
Accepted (ET)
Apr 26, 2018 · 8:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3,F4,F5Feb 26, 2018A12,615$0.00A60,004D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses